These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36157558)

  • 1. National Stop Transmission of Polio Program support for polio supplemental immunization activities in Nigeria 2012-2016: deployment of management support team.
    Edukugho AA; Waziri NE; Bolu O; Gidado SO; Okeke LA; Uba BV; Idris JM; Michael CA; Adegoke JO; Bammeke P; Adamu US; Nguku PM; Biya O; Ohuanbunwo CJ; Vertefeuille J; Damisa E; Wiesen E
    Pan Afr Med J; 2021; 40(Suppl 1):14. PubMed ID: 36157558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nigeria experience on the use of polio assets for the 2017/18 measles vaccination campaign follow-up.
    Oteri AJ; Adamu U; Dieng B; Bawa S; Terna N; Nsubuga P; Owoaje ET; Kassogue M; Jean Baptiste AE; Braka F; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C3-C11. PubMed ID: 33962837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polio Legacy in Action: Using the Polio Eradication Infrastructure for Measles Elimination in Nigeria-The National Stop Transmission of Polio Program.
    Michael CA; Waziri N; Gunnala R; Biya O; Kretsinger K; Wiesen E; Goodson JL; Esapa L; Gidado S; Uba B; Nguku P; Cochi S
    J Infect Dis; 2017 Jul; 216(suppl_1):S373-S379. PubMed ID: 28838182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of the contribution of National Stop Transmission of Polio Program to Nigeria's Immunization Program.
    Biya O; Archer WR; Rayner J; Welwean R; Jegede A; Jacenko S; Pallas S; Abimbola T; Ward K; Wiesen E
    Pan Afr Med J; 2021; 40(Suppl 1):1. PubMed ID: 36157560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress toward poliomyelitis eradication in Nigeria.
    Ado JM; Etsano A; Shuaib F; Damisa E; Mkanda P; Gasasira A; Banda R; Korir C; Johnson T; Dieng B; Corkum M; Enemaku O; Mataruse N; Ohuabunwo C; Baig S; Galway M; Seaman V; Wiesen E; Vertefeuille J; Ogbuanu IU; Armstrong G; Mahoney FJ
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S40-9. PubMed ID: 25316862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. World Health Organization's Innovative Direct Disbursement Mechanism for Payment of Grassroots Immunization Personnel and Operations in Nigeria: 2004-2015.
    Yehualashet YG; Wadda A; Agblewonu KB; Zhema T; Ibrahim AA; Corr A; Linkins J; Mkanda P; Vaz RG; Nsubuga P; Ashogbon D
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S108-15. PubMed ID: 26908746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategic Engagement of Technical Surge Capacity for Intensified Polio Eradication Initiative in Nigeria, 2012-2015.
    Yehualashet YG; Mkanda P; Gasasira A; Erbeto T; Onimisi A; Horton J; Banda R; Tegegn SG; Ahmed H; Afolabi O; Wadda A; Vaz RG; Nsubuga P
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S116-23. PubMed ID: 26912379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracking Vaccination Teams During Polio Campaigns in Northern Nigeria by Use of Geographic Information System Technology: 2013-2015.
    Touray K; Mkanda P; Tegegn SG; Nsubuga P; Erbeto TB; Banda R; Etsano A; Shuaib F; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S67-72. PubMed ID: 26609004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the Geographic Information System (GIS) in immunisation service delivery; its use in the 2017/2018 measles vaccination campaign in Nigeria.
    Oteri J; Idi Hussaini M; Bawa S; Ibizugbe S; Lambo K; Mogekwu F; Wiwa O; Seaman V; Kolbe-Booysen O; Braka F; Nsubuga P; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C29-C37. PubMed ID: 33478790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation after classification using lot quality assurance sampling: corrections for curtailed sampling with application to evaluating polio vaccination campaigns.
    Olives C; Valadez JJ; Pagano M
    Trop Med Int Health; 2014 Mar; 19(3):321-330. PubMed ID: 24382319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polio field census and vaccination of underserved populations--northern Nigeria, 2012-2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(33):663-5. PubMed ID: 23965829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the Stop Transmission of Polio (STOP) program in developing countries: the experience of Kenya.
    Tesfaye B; K Makam J; Sergon K; Onuekwusi I; Muitherero C; Sowe A
    BMC Public Health; 2020 Jul; 20(1):1110. PubMed ID: 32664859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strengthening facility-based immunization service delivery in local government areas at high risk for polio in Northern Nigeria, 2014-2015.
    Uba BV; Waziri NE; Akerele A; Biya O; Adegoke OJ; Gidado S; Ugbenyo G; Simple E; Usifoh N; Sule A; Kibret B; Franka R; Wiesen E; Elmousaad H; Ohuabunwo C; Esapa L; Mahoney F; Bolu O; Vertefeuille J; Nguku P
    Pan Afr Med J; 2021; 40(Suppl 1):6. PubMed ID: 36157565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Youth Group Engagement in Noncompliant Communities During Supplemental Immunization Activities in Kaduna, Nigeria, in 2014.
    Musa A; Mkanda P; Manneh F; Korir C; Warigon C; Gali E; Banda R; Umeh G; Nsubuga P; Chevez A; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S91-5. PubMed ID: 26609003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using data to improve outcomes of supplemental immunisation activities: 2017/2018 Nigeria measles vaccination campaign.
    Mogekwu FI; Oteri JA; Nsubuga P; Ezebilo O; Maxwell N; Wiwa O; Braka F; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C38-C45. PubMed ID: 33461831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of vaccination campaign effectiveness and population immunity to support and sustain polio elimination in Nigeria.
    Upfill-Brown AM; Voorman A; Chabot-Couture G; Shuaib F; Lyons HM
    BMC Med; 2016 Mar; 14():60. PubMed ID: 27029535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intervene before leaving: clustered lot quality assurance sampling to monitor vaccination coverage at health district level before the end of a yellow fever and measles vaccination campaign in Sierra Leone in 2009.
    Pezzoli L; Conteh I; Kamara W; Gacic-Dobo M; Ronveaux O; Perea WA; Lewis RF
    BMC Public Health; 2012 Jun; 12():415. PubMed ID: 22676225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Dedicated Mobile Teams and Polio Volunteer Community Mobilizers to Increase Access to Zero-Dose Oral Poliovirus Vaccine and Routine Childhood Immunizations in Settlements at High Risk for Polio Transmission in Northern Nigeria.
    Ongwae KM; Bawa SB; Shuaib F; Braka F; Corkum M; Isa HK
    J Infect Dis; 2017 Jul; 216(suppl_1):S267-S272. PubMed ID: 28838155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensified Local Resource Mobilization for the Polio Eradication Initiative: The Experience of World Health Organization in Nigeria During 2008-2015.
    Yehualashet YG; Horton J; Mkanda P; Vaz RG; Afolabi O; Gashu SG; Banda R; O'Malley H; Nsubuga P
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S101-7. PubMed ID: 26912380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revised Household-Based Microplanning in Polio Supplemental Immunization Activities in Kano State, Nigeria. 2013-2014.
    Gali E; Mkanda P; Banda R; Korir C; Bawa S; Warigon C; Abdullahi S; Abba B; Isiaka A; Yahualashet YG; Touray K; Chevez A; Tegegne SG; Nsubuga P; Etsano A; Shuaib F; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S73-8. PubMed ID: 26908755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.